Abstract
Statins are widely used for dyslipidemia treatment. Because these drugs inhibit intracellular cholesterol production, it is believed that they generate, as a secondary effect, an increase in the quantity and activity (up-regulation) of LDL receptors (LDLR) in the cellular surface, as this enhances the absorption of LDL structural cholesterol. Despite their high therapeutic efficacy, stati…